Literature DB >> 12632489

Methylation and mutation analysis of p16 gene in gastric cancer.

Yi Ding1, Xiao-Ping Le, Qin-Xian Zhang, Peng Du.   

Abstract

AIM: To study methylation, frequencies of homozygous deletion and mutation of p16 gene in gastric carcinoma.
METHODS: The methylation pattern in exon 1 and exon 2 of p16 gene was studied with polymerase chain reaction (PCR), using methylation sensitive restriction endonuclease HpaII and methylation insensitive restriction endonuclease MspI. PCR technique was used to detect homozygous deletions of exon 1 and exon 2 of p16 gene and single strand conformation polymorphism (SSCP) technique was used to detect the mutation of the gene.
RESULTS: Hypermethylation changes in exon 1 and exon 2 of p16 gene were observed in 25 % and 45 % of 20 gastric cancer tissues, respectively, while no methylation abnormality was found in normal tissues. The homozygous deletion frequency of exon 1 and exon 2 of p16 gene in 20 gastric cancer tissues was 20 % and 10 %, respectively. No mutation was found in exon 1 of p16 gene, while abnormal single strands were found in 2 (10 %) cases in exon 2 as detected by SSCP.
CONCLUSION: The results suggest that hypermethylation and abnormality of p16 gene may play a key role in the progress of gastric cancer. Hypermethylation of exon 2 of p16 gene may have effects on the carcinogenesis of gastric mucosa and may be a later event.

Entities:  

Mesh:

Year:  2003        PMID: 12632489      PMCID: PMC4621553          DOI: 10.3748/wjg.v9.i3.423

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa.

Authors:  Jing Zhang; Mao-De Lai; Jian Chen
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer.

Authors:  X S He; Q Su; Z C Chen; X T He; Z F Long; H Ling; L R Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  [Deletion and down-regulation of mts1/p16 gene in human gastric cancer].

Authors:  Y Lu; C Gao; J Cui
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1996-05

4.  Methylation of exon 2 of p16 is associated with late stage oesophageal cancer.

Authors:  S Kempster; W A Phillips; S Baindur-Hudson; R J Thomas; C Dow; S P Rockman
Journal:  Cancer Lett       Date:  2000-03-13       Impact factor: 8.679

Review 5.  Role of the p16 tumor suppressor gene in cancer.

Authors:  W H Liggett; D Sidransky
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

6.  High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.

Authors:  K Hayashi; R Metzger; D Salonga; K Danenberg; L P Leichman; U Fink; A Sendler; D Kelsen; G K Schwartz; S Groshen; H J Lenz; P V Danenberg
Journal:  Oncogene       Date:  1997-09-18       Impact factor: 9.867

7.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.

Authors:  M Gonzalez-Zulueta; C M Bender; A S Yang; T Nguyen; R W Beart; J M Van Tornout; P A Jones
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

Review 8.  Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.

Authors:  P M Pollock; J V Pearson; N K Hayward
Journal:  Genes Chromosomes Cancer       Date:  1996-02       Impact factor: 5.006

9.  Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.

Authors:  Y Y Lee; S H Kang; J Y Seo; C W Jung; K U Lee; K J Choe; B K Kim; N K Kim; H P Koeffler; Y J Bang
Journal:  Cancer       Date:  1997-11-15       Impact factor: 6.860

10.  Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.

Authors:  T Mori; K Miura; T Aoki; T Nishihira; S Mori; Y Nakamura
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

View more
  14 in total

1.  Apoptosis of human gastric adenocarcinoma cells induced by beta-ionone.

Authors:  Jia-Ren Liu; Bing-Qing Chen; Bao-Feng Yang; Hong-Wei Dong; Chang-Hao Sun; Qi Wang; Guo Song; You-Qiang Song
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case-control study in North Indian population.

Authors:  Marjan Askari; Ranbir Chander Sobti; Mohsen Nikbakht; Suresh C Sharma
Journal:  Mol Biol Rep       Date:  2013-05-28       Impact factor: 2.316

3.  Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus.

Authors:  Xiao-Mou Peng; Xue-Juan Chen; Jian-Guo Li; Lin Gu; Yang-Su Huang; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

4.  p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.

Authors:  Mohammad Reza Abbaszadegan; Omeed Moaven; Hamid Reza Sima; Kamran Ghafarzadegan; Azadeh A'rabi; Mohammad Naser Forghani; Hamid-Reza Raziee; Ali Mashhadinejad; Mostafa Jafarzadeh; Ehsan Esmaili-Shandiz; Ezzat Dadkhah
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

5.  Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer.

Authors:  Yusuke Takashima; Shuhei Komatsu; Takuma Ohashi; Jun Kiuchi; Hajime Kamiya; Hiroki Shimizu; Tomohiro Arita; Hirotaka Konishi; Atsushi Shiozaki; Takeshi Kubota; Kazuma Okamoto; Hitoshi Fujiwara; Hitoshi Tsuda; Eigo Otsuji
Journal:  Cancer Sci       Date:  2022-04-01       Impact factor: 6.518

6.  Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.

Authors:  S Komatsu; D Ichikawa; S Hirajima; H Nagata; Y Nishimura; T Kawaguchi; M Miyamae; W Okajima; T Ohashi; H Konishi; A Shiozaki; H Fujiwara; K Okamoto; H Tsuda; I Imoto; J Inazawa; E Otsuji
Journal:  Br J Cancer       Date:  2014-10-16       Impact factor: 7.640

7.  GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.

Authors:  Lars Lohne Eftang; Jovana Klajic; Vessela N Kristensen; Jörg Tost; Qin Ying Esbensen; Gustav Peter Blom; Ida Rashida Khan Bukholm; Geir Bukholm
Journal:  BMC Cancer       Date:  2016-03-16       Impact factor: 4.430

8.  Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma.

Authors:  Hiroki Kobayashi; Shuhei Komatsu; Daisuke Ichikawa; Tsutomu Kawaguchi; Shoji Hirajima; Mahito Miyamae; Wataru Okajima; Takuma Ohashi; Toshiyuki Kosuga; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Hitoshi Tsuda; Eigo Otsuji
Journal:  Oncotarget       Date:  2015-11-03

9.  Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma.

Authors:  Zhengrong Wu; Lirong Wu; Desheng Weng; Dazhi Xu; Jian Geng; Fei Zhao
Journal:  J Exp Clin Cancer Res       Date:  2009-01-15

10.  Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma.

Authors:  Y Nishimura; S Komatsu; D Ichikawa; H Nagata; S Hirajima; H Takeshita; T Kawaguchi; T Arita; H Konishi; K Kashimoto; A Shiozaki; H Fujiwara; K Okamoto; H Tsuda; E Otsuji
Journal:  Br J Cancer       Date:  2013-02-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.